The company trades on the Nasdaq Capital Market and Tel Aviv Stock Exchange. In other recent news, XTL Biopharmaceuticals has been notified by Nasdaq of its intention to delist the company’s American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results